Fibromuscular Dysplasia – RDG
- Aims of the Group
The main objectives of the Fibromuscular Dysplasia Rare Disease Group are to:
- Raise awareness and provide advice about the best strategy for the diagnosis and management of this still underdiagnosed disease.
- Study the presentation of the disease and baseline patient demographics.
- Study the prevalence of different subtypes of Fibromuscular Dysplasia, the incidence and determinants of disease progression/extension and complications
- Develop a Register of long term impact of intervention, as part of RaDaR
- Current Activities
The RDG will initially focus on a review of current evidence to provide guidance on:
- who to screen
- family screening
- managing children and adults with Fibromuscular Dysplasia
- molecular testing
- monitoring disease progression
- management of hypertension.
- International Links
The group have liaised with Dr Persu who has a longstanding interest in Fibromuscular Dysplasia with international links and established the European Fibromuscular Dysplasia registry.
- Patient Support Groups
There is no charity or support group for Fibromuscular Dysplasia in the UK as yet. This is in contrast to the very active Fibromuscular Dysplasia Society of America.
- Group Members
- Dr Tina Chrysochou, Consultant Nephrologist, Salford Royal Hospital RDG Lead
- Miss Jennifer Drai, Patient Representative
- Dr Graham Lipkin, Consultant Nephrologist, Queen Elizabeth Hospital Birmingham
- Prof Una Martin, Professor of Clinical Pharmacology and Hypertension Lead, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham
- Prof Alexandre Persu, Collaborator from European FMD Registry, Cliniques Universitaires Saint-Luc, Brussels
- Dr Peter Riley Consultant Diagnostic and Interventional Radiologist, Queen Elizabeth Hospital Birmingham
- Disclosure of Conflicts of Interest
Written by the Fibromuscular Dysplasia Rare Disease Group